Produced in rabbits immunized with E. coli-derived Human KLF6 fragment, and purified by antigen affinity chromatography.
Source
Polyclonal Rabbit IgG
Purification
Protein A & Antigen Affinity
Formulation
PBS, pH7.0 with 0.03% Proclin300
Conjugate
Unconjugated
Form
Liquid
Shipping
This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Storage
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Avoid repeated freeze-thaw cycles.
Immunochemical staining of human KLF6 in human gallbladder with rabbit polyclonal antibody at 1:2000 dilution, formalin-fixed paraffin embedded sections.
Immunochemical staining of human KLF6 in human gallbladder with rabbit polyclonal antibody at 1:2000 dilution, formalin-fixed paraffin embedded sections.
Kruppel like factor 6 (KLF6), a member of the KLF family, which has a classic zinc finger structure, is broadly considered to have anticancer activity. The Krüppel-like zinc finger transcription factor (KLF6) gene encodes a family of proteins generated through alternative splicing involved in the regulation of cancer development and progression. Alternative splicing of the KLF6 gene results in the production of at least four alternatively spliced isoforms. The full-length form of the KLF6 gene is a tumor suppressor gene that is frequently inactivated by loss of heterozygosity (LOH), somatic mutation, and/or decreased expression in human cancer. The transcription factor Krüppel-like factor 6 (KLF6) regulates various cellular functions, such as metabolism, cell proliferation, and differentiation. The transcription factor KLF6 has an essential role in the development and metastasis of multiple human cancers.
References
Zhang B, et al. (2018) Expression of klf6-sv2 in colorectal cancer and its impact on proliferation and apoptosis. Eur J Cancer Prev 27 (1): 20-26.
Gao Y, et al. (2017) Klf6 suppresses metastasis of clear cell renal cell carcinoma via transcriptional repression of e2f1. Cancer Res 77 (2): 330-342.
DiFeo A, et al. (2009) The role of klf6 and its splice variants in cancer therapy. Drug Resist Updat 12 (1-2): 1-7.
Debouki-Joudi S, et al. (2018) Overexpression of the oncogenic variant (klf6-sv1) in young npc patients and correlation with lack of e-cadherin. Anal Cell Pathol (Amst) 2018 9654067.